未登录

A

Alpár Horváth

Hungarian Academy of Sciences

H指数:12

被引数:389

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vitamin D and Colorectal Cancer Prevention: Immunological Mechanisms, Inflammatory Pathways, and Nutritional Implications

维生素D与结直肠癌预防：免疫学机制、炎症通路及营养学意义

IF5

2025-04-151

OA

Effect of non-spherical shape of dry powder aerosol drugs on their airway deposition distribution

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2025-02-010

OAAI

Effects of one year treatment with extrafine fixed triple inhaled therapy in moderate COPD in a real-life setting - results of the RATIONALE study

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Creating respiratory pathogen-free environments in healthcare and nursing-care settings: a comprehensive review

IF5.4

2024-10-110

OAAI

Comparative study of the inhalation parameters of COPD patients through NEXThaler® and Ellipta® dry powder inhalers

RESPIRATORY MEDICINE

IF3.1

2024-04-013

OAAI

The effect of lung emptying before the inhalation of aerosol drugs on drug deposition in the respiratory system

international journal of pharmaceutics

IF6.4

2023-12-015

OAAI

The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions

international journal of pharmaceutics

IF6.4

2023-12-019

OAAI

Comparative Analysis of COVID-19 Vaccination Coverage in the Hungarian Population and COPD Patients.

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

The effect of lung emptying on the breathing parameters characterizing the inhalation of aerosol drugs

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

The effect of lung emptying on the airway deposition of aerosol drugs

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Size distribution and relationship of airborne SARS-CoV-2 RNA to indoor aerosol in hospital ward environments

SCIENTIFIC REPORTS

IF3.9

2023-03-0212

OAAI

Do we really target the receptors? Deposition and co-deposition of ICS-LABA fixed combination drugs

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2022-07-015

OA

Modeling of nursing care-associated airborne transmission of SARS-CoV-2 in a real-world hospital setting

IF5.4

2022-01-053

OAAI

Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load

JOURNAL OF HOSPITAL INFECTION

IF3.1

2021-12-015

OAAI

Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2020-11-0118

OAAI

Numerical simulation of the effect of inhalation parameters and disease severity on the deposition of dry powder aerosol drugs in COPD patients

EUROPEAN RESPIRATORY JOURNAL

IF21

2020-10-280

PRE

Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection

RESPIRATORY MEDICINE

IF3.1

2019-07-0123

OAAI

Effect of delayed pMDI actuation on the lung deposition of a fixed-dose combination aerosol drug

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2018-08-0114

OAAI

Experimental and computational study of the effect of breath-actuated mechanism built in the NEXThaler® dry powder inhaler

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2017-11-0123

OAAI

Significance of breath-hold time in dry powder aerosol drug therapy of COPD patients

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2017-06-0139

PREAI